Search
peripheral artery stent
Indications:
- stenosis or occlusion of the superficial femoral artery in patients with peripheral artery disease
Contraindications:
- stenoses that cannot be dilated
- bleeding disorders
- pregnancy, breast-feeding, or planning to become pregnant within 5 years
Complications:
- restenosis necessitating additional therapy
- paclitaxel-coated devices (balloons & stents) associated with increased mortality (RR=1.9 at 4-5 years) [2]
Mechanism of action:
- paclitaxel-coated stent
- dual antiplatelet therapy for life [3]
General
vascular stent/vascular stenting
References
- FDA News Release: Nov. 15, 2012
FDA approves first drug-eluting stent to treat peripheral arterial disease
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm327068.htm
- Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D.
Risk of death following application of paclitaxel-coated balloons
and stents in the femoropopliteal artery of the leg: A systematic
review and meta-analysis of randomized controlled trials.
J Am Heart Assoc 2018 Dec 18; 7:e011245
PMID: 30561254 Free Article
https://www.ahajournals.org/doi/10.1161/JAHA.118.011245
- VAMC pharmacy